drugset / Trial / NCT02125188

Effects of Desmopressin on Blood Loss and the Quality of the Surgical Field During Endoscopic Sinus Surgery

NCT02125188

Phase 4 Completed 60 enrolled Tao Zhang
RandomizedParallel-groupDouble-blindPrevention

Summary

Bleeding during functional endoscopic sinus surgery (FESS) is a challenge for both surgeons and anesthesiologists despite several measures available for improving the surgical field. This study was conducted to evaluate the effect of desmopressin on blood loss and the quality of the surgical field in FESS.

Timeline

Start
2014-01
Primary completion
2014-08
Completion
2014-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Desmopressin Peptide 3 ug/kg Intravenous

Indications

No indication recorded.